Oncotarget

publication venue for

Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM. 2017
Targeting GITR in cancer immunotherapy - there is no perfect knowledge.. 14. 2023
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers.. 13. 2022
The role of immune surveillance in malignant transformation of benign salivary gland tumors.. 12. 2021
Deconstructing tumor heterogeneity: the stromal perspective.. 11. 2020
A 3D biofabricated cutaneous squamous cell carcinoma tissue model with multi-channel confocal microscopy imaging biomarkers to quantify antitumor effects of chemotherapeutics in tissue.. 11. 2020
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. 11. 2020
Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.. 11. 2020
Exercise reduces immune suppression and breast cancer progression in a preclinical model.. 11. 2020
Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis.. 10. 2019
Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.. 10. 2019
Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.. 10. 2019
ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer.. 10. 2019
Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epithelium.. 10. 2019
Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells.. 10. 2019
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins.. 10. 2019
Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone.. 10. 2019
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer.. 9. 2018
Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance.. 9. 2018
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation.. 9. 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications.. 9. 2018
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus.. 9. 2018
Activity of roniciclib in medullary thyroid cancer.. 9. 2018
Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study.. 9. 2018
Oncodriver inhibition and CD4⁺ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies.. 9. 2018
Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells.. 9. 2018
Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively.. 9. 2018
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer.. 9. 2018
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer.. 9. 2018
Analysis of hematological parameters as prognostic markers for toxicity and survival of ²²³Radium treatment.. 9. 2018
Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality.. 9. 2018
Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration.. 9. 2018
Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.. 9. 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia.. 9. 2018
The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling.. 9. 2018
The protein kinase SIK downregulates the polarity protein Par3.. 9. 2017
Competing risks and cancer-specific mortality: why it matters.. 9. 2017
Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment.. 9. 2017
Anti-neoplastic drugs increase caveolin-1-dependent migration, invasion and metastasis of cancer cells.. 8. 2017
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project.. 9. 2017
Hypoxia-inducible factor-1α regulates microglial functions affecting neuronal survival in the acute phase of ischemic stroke in mice.. 8. 2017
Detection of HPV related oropharyngeal cancer in oral rinse specimens.. 8. 2017
Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.. 8. 2017
Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.. 8. 2017
Lysosome-targeting agents in cancer therapy.. 8. 2017
LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.. 8. 2017
Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites.. 8. 2017
Differential response to exercise in claudin-low breast cancer.. 8. 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation.. 8. 2017
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1.. 8. 2017
Activating mutation of PDGFRB gene in a rare cardiac undifferentiated intimal sarcoma of the left atrium: a case report.. 8. 2017
High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation.. 8. 2017
MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G_D2 immunotherapy.. 8. 2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis.. 8. 2017
Targeting of PHOX2B expression allows the identification of drugs effective in counteracting neuroblastoma cell growth.. 8. 2017
Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells.. 8. 2017
In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME).. 8. 2017
Aurora kinase B dependent phosphorylation of 53BP1 is required for resolving merotelic kinetochore-microtubule attachment errors during mitosis.. 8. 2017
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.. 8. 2017
Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non-small cell lung cancer harboring EGFR mutations.. 8. 2017
Effects of roniciclib in preclinical models of anaplastic thyroid cancer.. 8. 2017
Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells.. 8. 2017
Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma.. 8. 2017
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models.. 8. 2017
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.. 8. 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition.. 8. 2017
Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.. 8. 2017
AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.. 8. 2017
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.. 8. 2017
Inhibition of colorectal cancer genomic copy number alterations and chromosomal fragile site tumor suppressor FHIT and WWOX deletions by DNA mismatch repair.. 8. 2017
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer.. 8. 2017
PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer.. 8. 2017
Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma.. 8. 2017
Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks.. 8. 2017
PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.. 8. 2017
Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression.. 8. 2017
MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.. 8. 2017
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.. 8. 2017
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.. 8. 2017
Oxidative stress induced by Se-deficient high-energy diet implicates neutrophil dysfunction via Nrf2 pathway suppression in swine.. 8. 2017
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer.. 8. 2017
Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model.. 8. 2017
Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells.. 8. 2017
Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.. 8. 2017
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing.. 8. 2017
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.. 7. 2016
OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations.. 7. 2016
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies.. 7. 2016
Acid ceramidase is upregulated in AML and represents a novel therapeutic target.. 7. 2016
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.. 7. 2016
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.. 7. 2016
Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells.. 7. 2016
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.. 7. 2016
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.. 7. 2016
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.. 7. 2016
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.. 7. 2016
IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.. 7. 2016
Scaffold attachment factor A (SAF-A) and Ku temporally regulate repair of radiation-induced clustered genome lesions.. 7. 2016
Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma.. 7. 2016
YKT6 expression, exosome release, and survival in non-small cell lung cancer.. 7. 2016
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.. 7. 2016
The essential role of GATA transcription factors in adult murine prostate.. 7. 2016
STAT5 induces miR-21 expression in cutaneous T cell lymphoma.. 7. 2016
Targeting cancer stem cells with p53 modulators.. 7. 2016
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein.. 7. 2016
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.. 7. 2016
Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.. 7. 2016
Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.. 7. 2016
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.. 7. 2016
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.. 7. 2016
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.. 7. 2016
The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors.. 7. 2016
Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma.. 7. 2016
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.. 7. 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.. 7. 2016
CXCL16 regulates cisplatin-induced acute kidney injury.. 7. 2016
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.. 7. 2016
Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers.. 7. 2016
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.. 7. 2016
MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor.. 7. 2016
Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair.. 7. 2016
Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.. 7. 2016
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.. 7. 2016
Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.. 7. 2016
VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin phosphorylation in endothelial cells.. 7. 2016
Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib.. 7. 2016
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.. 7. 2016
Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3.. 7. 2016
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.. 7. 2016
Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation.. 7. 2016
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.. 7. 2016
Morphometric analysis of immunoselection against hyperploid cancer cells.. 6. 2015
MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.. 6. 2015
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.. 6. 2015
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.. 6. 2015
Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment.. 6. 2015
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.. 6. 2015
Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration.. 6. 2015
Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition.. 6. 2015
Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology.. 6. 2015
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.. 6. 2015
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.. 6. 2015
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.. 6. 2015
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials.. 6. 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.. 6. 2015
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?. 6. 2015
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment.. 6. 2015
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.. 6. 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.. 6. 2015
Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.. 6. 2015
Quantification of cellular viability by automated microscopy and flow cytometry.. 6. 2015
Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.. 6. 2015
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition.. 6. 2015
Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.. 6. 2015
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.. 6. 2015
Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model.. 6. 2015
HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.. 6. 2015
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.. 6. 2015
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.. 5. 2014
Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells.. 5. 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells.. 5. 2014
MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.. 5. 2014
Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer.. 5. 2014
Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma.. 4. 2013
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.. 4. 2013
Small-Molecule targeting of translation initiation for cancer therapy.. 4. 2013
Effects of CT-Xp gene knock down in melanoma cell lines.. 4. 2013
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.. 3. 2012
Sox9 is required for prostate development and prostate cancer initiation.. 3. 2012
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).. 2. 2011
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.. 2. 2011
The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.. 1. 2010
A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.. 1. 2010
CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells.. 1. 2010
Correction: Discovery and clinical introduction of first-in-class imipridone ONC201.. 12. 2021
Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.. 11. 2020
It's a numbers game-density-dependent MMP activity mediates cancer cell migration. 2018
Neglected players: Tumor associated neutrophils involvement in chronic lymphocytic leukemia progression.. 10. 2019
MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer.. 9. 2018
Disabling an oncogenic transcription factor by targeting of control kinases.. 9. 2018
Avelumab demonstrates promise in advanced NSCLC.. 8. 2017
Multiple arterial grafting and ostriches: let's all take heart!. 8. 2017
Amino acid deprivation promotes intestinal homeostasis through autophagy.. 7. 2016
Lessons learned from a SIRT2-selective inhibitor.. 7. 2016
Defective autophagy gets to the brain.. 6. 2015
RBP-J and ITAM crosstalk.. 6. 2015
Fatty acid synthesis and NLRP3-inflammasome.. 6. 2015
Microbial control of intestinal innate immunity.. 6. 2015
BRAF-mutant hematopoietic malignancies.. 5. 2014
Asymmetric division: a marker for cancer stem cells in early stage tumors?. 4. 2013
Reaching un-drugable intracellular targets with the long arm of antibodies.. 4. 2013
Targeting lymphomas through MALT1 inhibition.. 3. 2012
Immunosurveillance against cancer-associated hyperploidy.. 3. 2012
Attacking tumor cells with a dual ligand for innate immune receptors.. 3. 2012
Resistance to EGFR inhibitors: molecular determinants and the enigma of head and neck cancer.. 2. 2011
Circulating tumor cells in the cerebrospinal fluid: "tapping" into diagnostic and predictive potential.. 2. 2011
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials. 2017
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy? 2017
Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. 2017
Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. 2017
The heterogeneous landscape of ALK negative ALCL. 2017
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application. 2017
The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review. 2017
Developmental therapeutics for inflammatory breast cancer: Biology and translational directions. 2017
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials. 2017
Discovery and clinical introduction of first-in-class imipridone ONC201. 2016
Addressing intra-tumoral heterogeneity and therapy resistance. 2016
Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities. 2016
Classification of current anticancer immunotherapies. 2014

VIVO Weill Cornell Medical College

Oncotarget Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

Electronic International Standard Serial Number (EISSN)